Study on safety of malaria drugs for coronavirus retracted

Study on safety of malaria drugs for coronavirus retracted

Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were not able to verify information that’s been widely questioned by other scientists.

Thursday’s retraction in the journal Lancet involved a May 22 report on hydroxychloroquine and chloroquine, drugs long used for preventing or treating malaria but whose safety and effectiveness for COVID-19 are unknown.

The study leaders also retracted an earlier report using the same company’s database on blood pressure drugs published by the New England Journal of Medicine. That study suggested that widely used blood pressure medicines were safe for coronavirus patients, a conclusion some other studies and heart doctor groups also have reached.

Even though the Lancet report was not a rigorous test, the observational study had huge impact because of its size, reportedly involving more than 96,000 patients and 671 hospitals on six continents.

Its conclusion that the drugs were tied to a higher risk of death and heart problems in people hospitalized with COVID-19 led the World Health Organization to temporarily stop use of hydroxychloroquine in a study it is leading, and for French officials to stop allowing its use in hospitals there.

“Not only is there no benefit, but we saw a very consistent signal of harm,” study leader Dr. Mandeep Mehra of Brigham and Women’s Hospital in Boston told The Associated Press when the work was published.

The drugs have been controversial because President Donald Trump repeatedly promoted their use and took hydroxychloroquine himself to try to prevent infection after some White House staffers tested positive for the virus. The drugs are known to have potential side effects, especially heart rhythm problems.

The Lancet study relied on a database from a Chicago company, Surgisphere. Its founder, Dr. Sapan Desai, is one of the authors.

Dozens of scientists questioned irregularities and improbable findings in the numbers, and the other authors besides Desai said earlier this week that an independent audit would be done. In the retraction notice, those authors say Surgisphere would not give the reviewers the full data, citing confidentiality and client agreements.

“Based on this development, we can no longer vouch for the veracity of the primary data sources” and must retract the report, they wrote.

“I no longer have confidence in the origination and veracity of the data, nor the findings they have led to,” Mehra said in a separate statement Thursday.

The Lancet’s notice said “there are many outstanding questions about Surgisphere and the data that were allegedly included in this study,” and “institutional reviews of Surgisphere’s research collaborations are urgently needed.”

Desai and Surgisphere did not immediately respond to request for comments sent to phone numbers and email address listed on the company’s materials.

The retraction shows “the system works,” said Dr. Ashish Jha, director of Harvard’s Global Health Institute. The pace of publishing scientific research has sped up in reaction to the pandemic, Jha said, leading to errors.

As long as errors are acknowledged, the pace seems justifiable because waiting a year or two for results to be published “is way too slow for this pandemic.”

“Part of the problem is people are so anxious. They want a definite answer yes or no,” Jha said. “We’re moving as fast as we can in science, but we can’t overreact to any single study.”

___

Associated Press writers Carla K. Johnson in Seattle and Candice Choi in New York contributed reporting.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Marilynn Marchione, The Associated Press

Coronavirus

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Break and enter at the Wetaskiwin Heritage Museum

Wetaskiwin RCMP is seeking help from the public to identify two suspects.

230 new COVID-19 cases reported over the weekend

City of Red Deer has nine active cases

Father and his 9-year-old son rescued off of Miquelon Lake this weekend

Wetaskiwin/Camrose RCMP and EPS Air 1 rescue father and son on Miquelon Lake.

Canadian professional chuckwagon racer reflects on cancelled season

This year would have marked Troy Dorchester’s 28th year of racing.

Conservatives call for Trudeau to testify at committee on WE Charity deal

Ethics Commissioner Mario Dion is already investigating whether Trudeau violated the Conflict of Interest Act

QUIZ: Are you ready for a summer road trip?

How much do you really know about roads, motor vehicles and car culture? Take this quiz to find out.

Crowds in Sylvan Lake “commonplace” during summer months

The Town of Sylvan Lake looking for solutions from Province for large crowds not social distancing

Look out, Mars: Here we come with a fleet of spacecraft

Three countries sending unmanned spacecraft

Canmore RCMP respond to multiple hiking injury calls this weekend

EMS and RCMP responded to three separate and unrelated hiking accidents in Kananaskis Country.

How Conservative leadership hopefuls would address the WE scandal if they win

The ethics commissioner has been called in to see if Trudeau broke conflict-of-interest law

With debt, deficit numbers out, experts say Liberals need plan for growth

Borrowing will push the federal debt past $1 trillion by the end of the fiscal year

Most Read